-
Antiarrhythmic Drugs and KCa2 Channels in AF
2026-08-31
This 2017 study used automated whole-cell patch clamp to test whether antiarrhythmic drugs for atrial fibrillation directly inhibit human KCa2.2 and KCa2.3 channels. Dofetilide and propafenone showed inhibition, whereas Dronedarone was not among the active compounds, indicating that KCa2 channel modulation is unlikely to explain the principal clinical actions of most tested drugs at therapeutic exposure.
-
Axitinib (AG 013736): From Mechanism to Translation
2026-08-31
A mechanism-first guide to using Axitinib (AG 013736) in angiogenesis inhibition assays, VEGF signaling pathway modulation, and tumor xenograft studies—while improving the translational value of cancer biology research.
-
Kif9 and Centriolar Satellite Positioning
2026-08-30
Vicente et al. identify the kinesin Kif9 as a spatial regulator of centriolar satellites during interphase, linking satellite position to centrosomal proteostasis and mitotic fidelity. The study provides a mechanistic framework for understanding how premitotic centrosome organization influences spindle formation and chromosome segregation.
-
Beyond Viability: Measuring Drug Response in Cancer
2026-08-29
Hannah R. Schwartz’s dissertation examines why relative viability and fractional viability should not be treated as interchangeable measures of anticancer activity. Its central contribution is a framework for separating growth inhibition from cell killing and interpreting their different proportions and time courses in vitro.
-
Miltefosine Activates ERK in Neutrophil Differentiation
2026-08-28
The reference study identifies Miltefosine as an experimental strategy for leukopenia by showing that it promotes neutrophil differentiation through Ras/MEK/ERK pathway activation. Integrated cell, mouse, transcriptomic, network-pharmacology, docking, and inhibitor experiments connect this response to improved neutrophil function and recovery of irradiated bone marrow.
-
Resazurin Cell Viability Assay Kit in Redox Oncology
2026-08-28
Discover how the Resazurin Cell Viability Assay Kit can quantify drug responses while revealing important redox-related interpretation limits. Using parthenolide-treated lymphoid malignancy cells as a model, this guide connects assay chemistry with apoptosis validation and experimental design.
-
Cy7 NHS Ester (A8109): Practical Labeling Guide
2026-08-27
Cy7 NHS ester is a water-compatible near-infrared dye for bioimaging that supports amino-group labeling of proteins, peptides, and other biomolecules. It is useful when organic cosolvents may compromise a delicate sample, but freshly prepared solutions should be used promptly rather than stored long term.
-
RIPA Lysis Buffer (Strong): Reliable Cell Assays
2026-08-27
Learn how RIPA Lysis Buffer (Strong), SKU K1020, supports reproducible protein extraction after viability, proliferation, and cytotoxicity assays. This scenario-based guide connects formulation, sample handling, assay compatibility, and vendor-selection decisions to practical laboratory workflows.
-
5-Methyl-CTP for Modified mRNA Synthesis
2026-08-26
5-Methyl-CTP is a 5-methyl modified cytidine triphosphate used as a substrate for in vitro transcription of modified mRNA. Its product specifications support controlled reagent handling, while published RNA-modification literature indicates that biological effects depend on transcript design, incorporation, purification, and delivery context.
-
Recombinant Human Oncostatin M: Assay Guide
2026-08-26
Learn how Recombinant Human Oncostatin M (E.coli, Tag Free, Lyophilized), SKU P1045, can address variability in viability, proliferation, and cytokine-release assays. This scenario-based guide covers assay interpretation, reconstitution, controls, cross-model comparisons, and practical vendor-selection criteria.
-
Tetrahydromagnolol for CB2 Signaling Workflows
2026-08-25
Tetrahydromagnolol combines potent peripheral CB2 agonism with GPR55 antagonism, enabling pathway-resolved cannabinoid receptor research rather than single-endpoint screening. This guide translates those properties into receptor, inflammatory, migration, and GPCR-to-cytoskeleton workflows while clearly separating established evidence from testable applications.
-
TUDCA in ER Stress and Metabolic Research
2026-08-25
Tauroursodeoxycholic Acid, or TUDCA, is a taurine-conjugated bile acid derivative used to study ER stress, apoptosis, mitochondrial injury, and metabolic dysfunction. Its strongest value is as a hypothesis-testing chemical chaperone, not as a pathway-specific substitute for genetic or pharmacological validation.
-
Targeted EPO mRNA Nanoparticles for Spinal Cord Repair
2026-08-24
A 2026 Materials Today Bio study developed mannose-modified lipid nanoparticles to deliver erythropoietin mRNA to CD206-enriched inflammatory macrophages and microglia after spinal cord injury. In mice, localized EPO production reduced neuroinflammation and ferroptosis-associated damage while improving axonal preservation and motor recovery, providing a mechanistically informed framework for targeted mRNA nanotherapy.
-
CDK9 inhibitor A3294: Protocol and QC Guide
2026-08-24
CDK9 inhibitor A3294 provides selective CDK9 modulation for transcription elongation and defined HIV-1 propagation studies, with a reported IC50 of 39 nM and limited activity against the listed CDK family members. It is intended for focused pathway experiments rather than pan-CDK profiling, general cell cycle regulation, or long-term storage of working solutions.
-
InstaBlue Protein Stain Solution for Proteomics
2026-08-23
InstaBlue Protein Stain Solution streamlines protein electrophoresis analysis with fixation-free visualization in approximately 5 minutes and reported sensitivity down to 5 ng. Its methanol- and acetic acid-free formulation is especially useful when gel bands must move efficiently from biomedical research protein visualization to quantification or mass spectrometry.